Search for other papers by Sophie Demartin in
Google Scholar
PubMed
Search for other papers by Stefan Matei Constantinescu in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
Search for other papers by Raluca Maria Furnica in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Frederic Debiève in
Google Scholar
PubMed
Search for other papers by Maria-Cristina Burlacu in
Google Scholar
PubMed
Introduction Hypothyroidism diagnosed during pregnancy, whether subclinial or overt, is associated with adverse pregnancy and neonatal outcomes ( 1 ). Existing guidelines unanimously recommend the treatment of overt hypothyroidism (OH) in this
Search for other papers by Joke Marlier in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Jean Kaufman in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
Introduction Hypothyroidism indicates the pathological condition of thyroid hormone (TH) deficiency and when untreated, it can lead to severe health effects. Hypothyroidism can be categorised as primary (PHT) or central hypothyroidism (CHT
Search for other papers by Roberto Fiore in
Google Scholar
PubMed
Search for other papers by Stefano La Rosa in
Google Scholar
PubMed
Search for other papers by Silvia Uccella in
Google Scholar
PubMed
Search for other papers by Deborah Marchiori in
Google Scholar
PubMed
Search for other papers by Peter A Kopp in
Google Scholar
PubMed
Established facts Consumptive hypothyroidism is a rare paraneoplastic syndrome, resulting in the degradation of T4 and T3 by overexpression of deiodinase 3 in neoplastic tissue. It has been primarily observed in patients with hemangiomas
Search for other papers by Sébastien Verdickt in
Google Scholar
PubMed
Search for other papers by Falco Van Nes in
Google Scholar
PubMed
Search for other papers by Carolien Moyson in
Google Scholar
PubMed
Search for other papers by Toon Maes in
Google Scholar
PubMed
Search for other papers by Paul Van Crombrugge in
Google Scholar
PubMed
Search for other papers by Annick Van den Bruel in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Introduction Radioactive iodine (RAI) has been used for the treatment of patients with Graves’ hyperthyroidism since the 1950s. After a single RAI administration, patients ideally become euthyroid but frequently develop hypothyroidism. On the
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla Bøgelund Larsen in
Google Scholar
PubMed
Search for other papers by Kristian Hillert Winther in
Google Scholar
PubMed
Search for other papers by Per Karkov Cramon in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Nils Jakob Knudsen in
Google Scholar
PubMed
QualityMetric Inc, Johnston, Lincoln, Rhode Island, USA
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Search for other papers by Lutz Schomburg in
Google Scholar
PubMed
Search for other papers by Kamil Demircan in
Google Scholar
PubMed
Search for other papers by Thilo Samson Chillon in
Google Scholar
PubMed
Search for other papers by Jeppe Gram in
Google Scholar
PubMed
Search for other papers by Stinus Gadegaard Hansen in
Google Scholar
PubMed
Internal Medicine Research Unit, University Hospital of Southern Jutland, Aabenraa, Denmark
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Introduction Autoimmune thyroiditis (AIT) is the leading cause of hypothyroidism in iodine-sufficient countries ( 1 ). AIT is characterised by lymphocytic infiltration of the thyroid gland and the presence of autoantibodies against thyroid
Search for other papers by Hicham Benabdelkamel in
Google Scholar
PubMed
Search for other papers by Malak A Jaber in
Google Scholar
PubMed
Search for other papers by Lina A Dahabiyeh in
Google Scholar
PubMed
Search for other papers by Afshan Masood in
Google Scholar
PubMed
Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for other papers by Reem H Almalki in
Google Scholar
PubMed
Search for other papers by Mohthash Musambil in
Google Scholar
PubMed
Department of Medicine, College of Medicine and King Saud Medical City, King Saud University, Riyadh, Saudi Arabia
Search for other papers by Anas M Abdel Rahman in
Google Scholar
PubMed
Department of Biochemistry and Molecular Medicine, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
Search for other papers by Assim A Alfadda in
Google Scholar
PubMed
-stimulating hormone (TSH), total T 4 and T 3 , and free T 4 (FT 4 ) and T 3 . The other tests for thyroid antibodies and thyroglobulin identify autoimmune thyroid conditions and thyroiditis, respectively ( 4 ). Hypothyroidism, or an underactive thyroid, is a
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Kamilla R Riis in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla B Larsen in
Google Scholar
PubMed
Search for other papers by Bjarke R Medici in
Google Scholar
PubMed
Search for other papers by Christian Z Jensen in
Google Scholar
PubMed
Search for other papers by Kristian H Winther in
Google Scholar
PubMed
Search for other papers by Emil L Larsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Data and Data Support, Region Zealand, Sorø, Denmark
Search for other papers by Christina Ellervik in
Google Scholar
PubMed
Search for other papers by Jeppe L la Cour in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Thomas H Brix in
Google Scholar
PubMed
Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
Department of Cardiology, University Hospital Nordsjælland, Hillerød, Denmark
Search for other papers by Henrik E Poulsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
Introduction Hypothyroidism, most often caused by autoimmune thyroiditis, is a common disease with a prevalence of approximately 3% in the European population ( 1 ). Epidemiological studies have shown that hypothyroidism is associated with an
Search for other papers by Irene Campi in
Google Scholar
PubMed
Search for other papers by Marco Dell’Acqua in
Google Scholar
PubMed
Search for other papers by Elisa Stellaria Grassi in
Google Scholar
PubMed
Search for other papers by Maria Cristina Vigone in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Introduction Primary hypothyroidism is a very common endocrine disease, with up to 10–15% of the general population being affected with mild or subclinical forms, including undiagnosed cases ( 1 , 2 ). Since the consequences of untreated
Search for other papers by Giorgio Radetti in
Google Scholar
PubMed
Search for other papers by Franco Rigon in
Google Scholar
PubMed
Search for other papers by Alessandro Salvatoni in
Google Scholar
PubMed
Search for other papers by Irene Campi in
Google Scholar
PubMed
Search for other papers by Tiziana De Filippis in
Google Scholar
PubMed
Search for other papers by Valentina Cirello in
Google Scholar
PubMed
Search for other papers by Silvia Longhi in
Google Scholar
PubMed
Search for other papers by Fabiana Guizzardi in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Marco Bonomi in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Introduction Patients with congenital hypothyroidism (CH) display a certain degree of resistance to levothyroxine (LT4) either at birth or during childhood ( 1 , 2 ). This clinical picture usually improves later in life ( 1 ), although adult
Search for other papers by Emilie Brûlé in
Google Scholar
PubMed
Search for other papers by Xiang Zhou in
Google Scholar
PubMed
Search for other papers by Ying Wang in
Google Scholar
PubMed
Search for other papers by Evan R S Buddle in
Google Scholar
PubMed
Search for other papers by Luisina Ongaro in
Google Scholar
PubMed
Search for other papers by Mary Loka in
Google Scholar
PubMed
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada
Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada
Search for other papers by Daniel J Bernard in
Google Scholar
PubMed
Introduction Congenital central hypothyroidism (CCH) may affect as many as one in 13,000 people ( 1 ). In CCH, thyroid hormone levels are low to low-normal without the expected increases in thyrotropin (TSH), implicating defects in the brain